How do you decide?' Cancer patients die waiting for CAR-T therapy
By A Mystery Man Writer
“And people are dying. About 20% of all our patients together are actually dying before they can get CAR-T,” said Krina Patel, director of the myeloma cell therapy program at MD Anderson.
CAR T-Cell Therapy
Expanding the Horizons of CAR T Therapy Beyond Cancer Treatment: Part I
CAR-T-cell therapy opens up the world to lymphoma survivor
FDA investigating risk of secondary cancers after CAR-T therapy to treat cancer
The Latest in CAR-T Cell Therapy for Pediatric Cancer
CAR T-Cell Therapy, a Breakthrough Treatment for Cancer Patients
FDA investigating risk of secondary cancers after CAR-T therapy to treat cancer
How do you decide?' Cancer patients die waiting for CAR-T therapy
Living drug' offers hope to terminal blood cancer patients
Scientists engineer potent immune cells for 'off-the-shelf' cancer immunotherapy
Success Story: Canadian cancer survivor works with the NRC for broader access to CAR-T therapy
Cancer Therapy Breakthrough: First Patient Declared Free of Cancer – Indrosphere
Why New Cancer Treatment Discoveries are Proliferating
Lymphoma: Symptoms, Causes and Treatment
Immunotherapy for leukemia: Types, success rate, and more
